Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update — See source for full details.
$UNCY
Price history, market instrument context, member research, and related headlines in one place.
UNCY key statistics
NasdaqCMUSD
52-week range
$3.592%$8.74
Latest session $3.59–$3.81Unicycive Therapeutics, Inc. (UNCY) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $3.70, down $0.03 (0.80%) from the previous close of $3.73. It has traded between $3.59 and $3.81 in the latest session. Over the past year it has ranged from $3.59 to $8.74, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 1.2M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Unicycive Therapeutics (UNCY) Q2 GAAP EPS beats estimates; cash $61.4M as of June 30, 2026 extends runway into 2027—read the update now.
Loading $UNCY research…